Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Sales | 192 | 296 | 231 | 36 | 38 |
| Cost of Goods | 31 | 65 | 13 | 20 | 58 |
| Gross Profit | 161 | 231 | 217 | 16 | -21 |
| Operating Expenses | 1,297 | 1,009 | 1,526 | 1,233 | 926 |
| Operating Income | -1,105 | -713 | -1,295 | -1,196 | -889 |
| Other Income | 1,523 | 0 | 594 | -214 | -173 |
| Pre-tax Income | 418 | -713 | -701 | -1,410 | -1,062 |
| Net Income Continuous | 418 | -713 | -701 | -1,410 | -1,062 |
| Net Income Discontinuous | -25 | 3 | -71 | 20 | 64 |
| Minority Interests | -11 | -14 | N/A | N/A | N/A |
| Net Income | $404 | $-696 | $-621 | $-1,391 | $-998 |
| EPS Basic Total Ops | 0.09 | -0.24 | -0.26 | -0.50 | -0.38 |
| EPS Basic Continuous Ops | 0.10 | -0.24 | -0.25 | -0.50 | -0.40 |
| EPS Basic Discontinuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.02 |
| EPS Diluted Total Ops | 0.09 | -0.24 | -0.26 | -0.50 | -0.38 |
| EPS Diluted Continuous Ops | 0.10 | -0.24 | -0.25 | -0.50 | -0.40 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.00 | -0.01 | -0.01 | 0.02 |
| EBITDA(a) | $-1,077 | $-685 | $-1,233 | $-1,168 | $-861 |